Skip to main content
. 2020 Feb;11(1):61–67. doi: 10.21037/jgo.2019.11.06

Figure 1.

Figure 1

Treatment failure free survival and duration on study. (A) Shown is the treatment failure free survival for all patients; (B) shown is the duration on study of all patients. Eight patients remained on study with stable disease for greater than 3 months. Treatment was discontinued for progressive disease (#) or adverse events (*); one patient was censored (^) due to withdrawal of consent.